Substance P: a new era, a new role

Pharmacotherapy. 2001 Sep;21(9):1061-9. doi: 10.1592/phco.21.13.1061.34612.

Abstract

Substance P has been extensively studied and is considered the prototypic neuropeptide of the more than 50 known neuroactive molecules. The understanding of substance P has evolved beyond the original concept as the pain transmitter of the dorsal horn. Animal and genetic research, recent developments of nonpeptide substance P antagonists, and important changes in the understanding of neurotransmission have each contributed to the current understanding of substance P After 7 decades, the physiologic role of substance P is known as a modulator of nociception, involved in signaling the intensity of noxious or aversive stimuli. Genetic studies in mice and development of substance P antagonists provide more recent results that support the redefinition of the central role of substance P Evidence suggests that this neuropeptide is an integral part of central nervous system pathways involved in psychologic stress.

Publication types

  • Review

MeSH terms

  • Animals
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Aprepitant
  • Depression / drug therapy
  • Depression / physiopathology
  • Humans
  • Morpholines / pharmacology
  • Morpholines / therapeutic use
  • Neuropeptides / antagonists & inhibitors
  • Neuropeptides / physiology*
  • Pain / drug therapy
  • Pain / physiopathology
  • Stress, Psychological / physiopathology
  • Substance P / antagonists & inhibitors
  • Substance P / physiology*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Antidepressive Agents, Second-Generation
  • Morpholines
  • Neuropeptides
  • Aprepitant
  • Substance P